Go to news

.eu Web Awards finalists

SPIOMET4HEALTH and Kaila finalists for the .eu Web Awards 2022

eu web awards finalists

SPIOMET4HEALTH and KAILA websites have been selected as finalists in the eu Web Awards. SPIOMETH4HEALTH is finalist in “Laurels” category, aimed at websites dedicated to education or registered in a European project related to education, while KAILA is in “Leaders” category, which rewards nationally consolidated projects.

After the votation, SPIOMET4HEALTH, project in which Zabala Innovation participates as a partner, leading the Dissemination and Communication work packages, and Kaila have been one of the most voted projects.

As finalists, representatives of Zabala Innovation and the SPIOMET4HEALTH team will be able to attend the awards gala, which will take place on 17th November in Mechelen, Belgium.
The six winners will be selected and unveiled by the jury during the gala.

For their selection, the jury – consisting of Maria Rosa Gibellini, Roman Kabelka, Stefan Kolle, João Pedro Martins, and Philippe Vercamer – will choose from the three most voted projects in each category.

This recognition is an opportunity to visibilize and position Zabala Innovation’s expertise in the European framework.


About the .eu Web Awards: 

The .eu Web Awards  will reward the six winning projects with a marketing campaign worth €5,000 to be implemented in collaboration with EURid, a web management course, and an official certificate to identify their website and social media profiles. 

The winners will be selected by the jury from the 18 shortlisted projects, which will be announced on 1 September. The finalist will have the opportunity to attend the awards ceremony where the six winners, one for each category, will be revealed. The ceremony will take place on 17 November 2022 in Mechelen, Belgium.  

About the projects submitted by Zabala Innovation: 

SPIOME4THEALTH: is a European project coordinated by Fundació Sant Joan de Déu/ Hospital Sant Joan de Déu together with 16 other organisations. The project aims to provide a novel treatment for adolescent girls and young adult women with Polycystic Ovary Syndrome. PCOS negatively affects the health and quality of life of approximately 110 million women. It has an impact on the emotional, physical, social functioning and behaviour, and on family-related activities. 

Kaila: is a platform that understands the exact needs of its users and offers them tailor-made solutions. In this way, it allows them to obtain funding for projects, analyse innovation trends, carry out competitive monitoring and find partners and collaborators.